# Cognuse

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cognuse

- Industry: Healthcare IT
- Headquarters: San Diego, US
- Website: www.cognuse.com
- Total disclosed funding: $0.7M
- Latest round: Seed (May 1, 2016)
- Investors on record: 7

## About

Cognuse, Inc. is a healthcare technology company focused on enhancing patient rehabilitation through a comprehensive platform designed for critical care environments. Their innovative solutions support patient adherence and engagement in recovery processes.Founded in 2010 by Andres Mellik, Cognuse, Inc. is headquartered in San Diego, US. The company specializes in a rehabilitation platform designed to cater to healthcare facilities, rehabilitation centers, and outpatient programs. In January 2017, Cognuse raised USD 0.05 million in Seed funding from EASME, marking an important milestone in their funding journey. The company has successfully completed a total of six deals since its inception.Cognuse specializes in a comprehensive rehabilitation platform designed to support the continuum of care for patients, particularly in critical care environments. The core offerings include a Guidelines Adherence and Management System, an ICU dashboard, interactive educational content, and a virtual exercise program aimed at enhancing patient independence and engagement. These solutions provide healthcare professionals with actionable guidelines, real-time support, and tools to manage patient adherence and compliance effectively. Cognuse targets healthcare facilities, rehabilitation centers, and outpatient programs, with a focus on improving communication between patients and healthcare providers, thereby fostering active participation in recovery processes. The company's products are positioned in various geographical markets, specifically targeting the United States healthcare sector, where the demand for innovative rehabilitation solutions is rapidly increasing.Cognuse operates on a subscription-based revenue model, providing its comprehensive rehabilitation platform to healthcare facilities and professionals. Clients typically engage in partnerships that involve recurring transaction structures, allowing for ongoing access to the platform's services and resources. Revenue is generated through these subscription plans, which encompass a suite of tools designed for both patient empowerment and clinical support. The company’s flagship products, including the interactive ICU dashboard and virtual exercise programs, are integral to the offerings, allowing facilities to enhance their patient care protocols. Pricing structures for these services are tailored to client needs and may vary based on the scope of service required, ensuring a customized approach to rehabilitation support.Cognuse plans to leverage the recent Seed funding of USD 0.05 million raised in January 2017 to expand its product offerings and enhance its market presence. The company is developing new tools aimed at improving rehabilitation outcomes and increasing patient engagement, with launches expected in the coming years. Cognuse is also looking to enter new markets beyond the United States healthcare sector, focusing on regions where the demand for rehabilitation technology is growing. These initiatives aim to solidify Cognuse's position in the healthcare technology landscape and improve access to innovative rehabilitation solutions.

## Funding rounds

- Seed, May 1, 2016, $0.7M — Jumpstart Health Investors
- Seed, Apr 30, 2014, $0.1M — 500 Global, DreamIt Ventures, Accelerace, Jumpstart Health Investors, FJ Labs, BioHealth Innovation, Johns Hopkins Technology Ventures
- Seed, Jan 10, 2014 — DreamIt Ventures

## Investors

- DreamIt Ventures (https://capitalatlas.ai/funds/dreamit-ventures) — Seed
- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed
- Accelerace (https://capitalatlas.ai/funds/accelerace) — Seed
- Jumpstart Health Investors (https://capitalatlas.ai/funds/jumpstart-health-investors) — Seed
- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Seed
- BioHealth Innovation — Seed
- Johns Hopkins Technology Ventures (https://capitalatlas.ai/funds/johns-hopkins-technology-ventures) — Seed